
Pharmaceutical Executive
The healthcare industry’s ongoing shift from volume- to value-based contracting has set a compelling precedent for forward-thinking healthcare marketing agencies.

Pharmaceutical Executive
The healthcare industry’s ongoing shift from volume- to value-based contracting has set a compelling precedent for forward-thinking healthcare marketing agencies.

Pharmaceutical Executive
There are many factors involved in launching a drug but one prevailing goal: brand awareness. I caught up with Fingerpaint's Bryan O’Malley, who shared some of today's key digital trends affecting that mission.

Pharmaceutical Executive
Tech-driven changes to training and learning systems-and how brand information is provided and shared-are overhauling approaches to sales rep preparation.

Pharmaceutical Executive
Following a new product’s first year on the market, there are four key ways companies can refine commercial strategies to maximize product sales.

Pharmaceutical Executive
Pharm Exec’s annual feature profiling a selection of notable biopharma brands focuses this year on new beginnings and new promise-spotlighting five products with compelling product launch stories that tie strongly with the industry’s broader and evolving market-entry landscape.

Pharmaceutical Executive
The key ingredients for biopharma startups in building their brand story.

Pharmaceutical Executive
Why Key Online Influencers are so important and how to leverage them.

By the end of 2020, it is predicted that AI will create more jobs than it is taking. Should reps be concerned, asks David Logue.

Pharmaceutical Executive
Outlining three practices that are key to navigating today’s multiplayer agency landscape - and getting more value from each external vendor.

Pharmaceutical Executive
Strategies for pharma in delivering the full picture to patients.

Pharmaceutical Executive
Companies need to find compelling ways to present facts, rather than slick but insubstantial promotions.

Pharmaceutical Executive
A checklist of best practices for mid-life products a few years after launch to help companies with growing oncology portfolios determine not only to see if there’s hidden vitality still left in their aging brands.

Greg Flynn discusses the advantages, challenges and possible future of CCOs and outlines their role in effective sales strategy development.

Shrujitha Ramanujam outlines Unmetric's analysis of pharma's social media activity on LinkedIn and Facebook.

Gary Lyon explores the role and impact of three elements of marketing planning that drive business success: Segmentation, Targeting, and Positioning.

Pharmaceutical Executive
Sharon Callahan, this year’s Healthcare Businesswomen’s Association Woman of the Year, has built a career defined by an entrepreneurial drive to advance medical communications-and a commitment to breaking down barriers in the workplace and beyond.

Pharmaceutical Executive
Despite being the fastest growing influencers in healthcare, ad campaigns targeted at payers are often an afterthought.

Jean-Francois Denault outlines a systemic approach to evaluating the commercial viability of a product.

Clinical trials for precision therapies will require a healthy dose of education, collaboration, and data-driven decision-making from everyone involved in the process―not to mention a dedication to digital technology. Justin Grossman reports.

Creating a culture of analytics will help you get the most out of your marketing efforts, writes Justin Grossman.

Pharmaceutical Executive
Wide-ranging probes to target marketing, pricing, and access.

Kilian Weiss, Veeva Oncology Link General Manager, talks about how the Oncology Link offering has evolved and how it facilitates the process of identifying and approaching key opinion leaders.

Pharmaceutical Executive
Being more human in brand engagement doesn’t mean being less transparent

Like Facebook, many healthcare companies are trying to become more "like people", despite being anything but. They should instead prioritize transparency and engaging in knowledge-sharing with the public, writes Julia Stern,

Pharmaceutical Executive
Regulators, prosecutors shifting enforcement focus from off-label promotion to messages that raise safety issues, mislead.